Literature DB >> 10100321

Peptidoleukotriene (PLT) release and absorption from the airways of the isolated perfused guinea pig lung following chemical and antigenic challenge.

R A Kovelesky1, P R Byron, J Venitz.   

Abstract

PURPOSE: To study the release and absorption of peptidoleukotrienes (PLTs) from the airways of the guinea pig lung following calcium ionophore A23187 (CI), benzalkonium chloride (BAC), ethylene diamine tetra-acetic acid (EDTA) or ovalbumin (OA) challenge.
METHODS: PLT C4/D4/E4 were quantified in the perfusate of the isolated perfused guinea pig lung (IPGPL) following intratracheal administration of CI, BAC, EDTA or OA in different doses. The formation and airway-to-perfusate transfer kinetics of PLTs were analyzed by fitting mean data for cumulative PLT in perfusate vs. time to an A-->B-->C first-order release and transfer model, with dose-dependent transfer rate constants.
RESULTS: CI induced apparent first order release of PLTs with a t1/2 approximately equal to 1.2 minutes. The amount of PLT released was CI dose-dependent, as was the airway-to-perfusate transfer rate constant. These reached maxima of 0.254 microgram and 0.0557 min.-1, respectively, around a CI dose of 100 micrograms. In OA-sensitized IPGPL preparations, OA induced a similar dose-dependent release of PLTs, although the rates of PLT release were much greater and more variable than those seen with CI. In OA sensitized IPGPL preparations, at an OA dose of 1000 micrograms, the maximum amount of PLT released was 0.289 micrograms and the maximal airway-to-perfusate transfer rate constant was 0.0229 min-1. BAC and EDTA failed to induce quantifiable PLT release from the airways.
CONCLUSIONS: Rapid release of the inflammatory mediators, PLT C4/D4/E4, could be induced in the unsensitized IPGPL by CI, and in the sensitized IPGPL by OA. Transfer into perfusate occurred in both cases with dose-dependent t1/2 ranging from 12.4 through 57.8 minutes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10100321     DOI: 10.1023/a:1018801113797

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  18 in total

1.  Critical analysis of "flip-flop" phenomenon in two-compartment pharmacokinetic model.

Authors:  P R Byron; R E Notari
Journal:  J Pharm Sci       Date:  1976-08       Impact factor: 3.534

Review 2.  Preservatives in nebulizer solutions: risks without benefit.

Authors:  R Beasley; D Fishwick; J F Miles; L Hendeles
Journal:  Pharmacotherapy       Date:  1998 Jan-Feb       Impact factor: 4.705

3.  A novel dosing method for drug administration to the airways of the isolated perfused rat lung.

Authors:  P R Byron; R W Niven
Journal:  J Pharm Sci       Date:  1988-08       Impact factor: 3.534

4.  Release of leukotrienes in patients with bronchial asthma.

Authors:  S Lam; H Chan; J C LeRiche; M Chan-Yeung; H Salari
Journal:  J Allergy Clin Immunol       Date:  1988-04       Impact factor: 10.793

5.  Distribution and metabolism of leukotriene C4 after cisternal injection in guinea pigs.

Authors:  S K Juhn; L Orning; S Hammarström; P Hedqvist; J Wersäll
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  1989-06       Impact factor: 4.006

6.  Solute absorption from the airways of the isolated rat lung. IV. Mechanisms of absorption of fluorophore-labeled poly-alpha,beta-[N(2-hydroxyethyl)-DL-aspartamide].

Authors:  P R Byron; Z Sun; H Katayama; F Rypacek
Journal:  Pharm Res       Date:  1994-02       Impact factor: 4.200

7.  Inactivation of leukotriene C4 in the airways and subsequent urinary leukotriene E4 excretion in normal and asthmatic subjects.

Authors:  J Y Westcott; N F Voelkel; K Jones; S E Wenzel
Journal:  Am Rev Respir Dis       Date:  1993-11

8.  Solute absorption from the airways of the isolated rat lung. II. Effect of surfactants on absorption of fluorescein.

Authors:  R W Niven; P R Byron
Journal:  Pharm Res       Date:  1990-01       Impact factor: 4.200

9.  Urinary leukotriene E4 after exercise challenge in children with asthma.

Authors:  Y Kikawa; T Miyanomae; Y Inoue; M Saito; A Nakai; Y Shigematsu; S Hosoi; M Sudo
Journal:  J Allergy Clin Immunol       Date:  1992-06       Impact factor: 10.793

Review 10.  Eicosanoids and asthma: an update.

Authors:  F C Thien; E H Walters
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  1995-05       Impact factor: 4.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.